Late-onset encephalitis as an immune-related adverse event of avelumab therapy in a patient with Merkel cell carcinoma of unknown primary.
Nomura K, Ogura Y, Kageyama R, Watanabe K, Nakamura T, Honda T
European Journal of DermatologyIn the feed 6 Sep 2026, issue 2026 Aug 01, added to PubMed 6 Sep 2026
Topics: Skin cancer & tumors
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42702026 · DOI 10.1684/ejd.2026.5086